Trials / Completed
CompletedNCT05460260
Glucomen Day Cascade CGM System 21-Day Wear Study
GlucoMen Day Cascade CGM 21-Day Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (actual)
- Sponsor
- WaveForm Technologies Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Assessment of 21-day CGM wear period
Detailed description
This single-site study will include 10 subjects who will wear two CGMs for 21 days. On day 1, 5, 10, 15, and 21 subjects will be in-clinic for 12 hrs of testing with YSI blood glucose measurements taken every 15 minutes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cascade CGM | 21-days of CGM wear |
Timeline
- Start date
- 2020-09-12
- Primary completion
- 2020-09-27
- Completion
- 2020-11-15
- First posted
- 2022-07-15
- Last updated
- 2022-07-15
Locations
2 sites across 2 countries: Croatia, Slovenia
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05460260. Inclusion in this directory is not an endorsement.